2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit – UK Edition

The 2nd Annual EVIDENCE 360: RWE, Pricing & Market Access Summit is a leading UK conference focused on the growing role of Real World Evidence (RWE) in healthcare decision-making. As regulators, payers, and healthcare stakeholders increasingly rely on real-world data to evaluate value, safety, and outcomes, this summit provides a timely platform to explore best practices and future-ready strategies.

This two-day in-person event brings together professionals from pharmaceuticals, biotechnology, healthcare organizations, regulatory bodies, and payer communities. The agenda is designed to address critical challenges across evidence generation, HEOR, pricing and reimbursement, market access, and regulatory alignment throughout the product lifecycle.

What You’ll Learn

• How Real World Evidence supports pricing, reimbursement, and market access decisions
• Practical approaches to HEOR and value demonstration
• Regulatory and HTA expectations for RWE submissions
• Patient-centric outcomes and real-world data utilization
• Post-marketing evidence generation and pharmacovigilance
• The role of analytics, AI, and digital health in RWE

Who Should Attend

This conference is ideal for professionals working in pharmaceutical and biotechnology companies, HEOR and RWE teams, market access and pricing functions, regulatory affairs, pharmacovigilance, healthcare analytics, and outcomes research.

Why Attend

Participants will gain actionable insights, real-world case studies, and the opportunity to network with global decision-makers shaping evidence-led healthcare strategies.

Learn More & Register

https://realworldevidenceconference.com/upcoming-conferences/uk-edition/registration/

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Veridon Global